All In MedTech

Device Trial Radar · NCT07070089

BosSTENT ImpLant to trEat debilitatiNg Pulse-synchronous Tinnitus

Last checked: Nov 19, 2026Latest source record: Aug 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

90

Planned (sponsor's estimate)

Start

Feb 1, 2026

Primary completion

Jul 2027

Study completion Jul 2028

Sponsor

Lead sponsor
Sonorous NV, IncNot on our public-company list
Sponsor type
Industry
First posted
Jul 17, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is evaluating the safety and clinical performance of the BosSTENT, a new stent designed specifically for treating pulse-synchronous tinnitus due to venous sinus stenosis. The study will evaluate the long-term safety of the BosSTENT as well as its impact on the severity of pulse-synchronous tinnitus.

Conditions

  • Pulsatile Tinnitus
  • Venous Sinus Stenosis

Interventions

  • BosSTENT implantationDevice

    BosSTENT implantation in the transverse venous sinus

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of Major adverse events (MAE)Time frame: 3 months
  2. Improvement of pulse-synchronous tinnitus measured by a decrease of at least 2 grades or 40 points on the Tinnitus Handicap Inventory (THI)Time frame: 30 days

Locations

6 sites in 2 countries. Site status is shown where the registry gives one.

  • The Ottawa Hospital

    Ottawa, Canada, Canada · Recruiting

  • Unity Health Toronto - St. Michael's Hospital

    Toronto, Canada, Canada · Recruiting

  • CHU de Bordeaux

    Bordeaux, France, France · Recruiting

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.